Synergetics USA, Inc., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VersaVIT™, a novel vitrectomy system for the retinal surgery market.
Ophthalmics
Abbott Medical Claims Its Optics’ Tecnis Lens May Help Maintain Circadian Rhythm
Can the colour of your intraocular lenses affect your circadian rhythm and general health? Really? Our disbelief is suspended temporarily as Abbott Medical cites clinical evidence that it can.
FDA Approves First Glaucoma Stent For Use With Cataract Surgery
One of the smaller devices featured on our pages, but nonetheless significant. Californian ophthalmic device company Glaukos has gained FDA approval for its iStent device, which relieves intraocular pressure in glaucoma patients.
FDA Clears Bausch + Lomb’s enVista™ “Glistening Free” Intraocular Lens
Eye health company Bausch + Lomb claims its newly FDA approved IOL is uniquely able to claim to be glistening free.
Bioptigen’s Envisu™ Becomes First OCT System FDA Cleared For Hand-held Paediatric Ophthalmic Imaging
Bioptigen Inc. has received FDA 510(k) clearance to begin marketing its hand-held Envisu Spectral Domain Ophthalmic Imaging System (SDOIS) for patient use. In receiving this regulatory clearance, Bioptigen’s Envisu SDOIS become the first optical coherence tomography(OCT) imaging system commercially available in the United States for hand-held and paediatric imaging.
FDA Clears Abbott’s iFS Advanced Femtosecond Laser For Arcuate Incisions In Cataract Surgery
Femtosecond laser technology is fairly new to the ophthalmic surgical profession, especially in the US. Now FDA has cleared Abbott’s device for the creation of curved incisions in corneal surgery including cataract access.
Carbon-based Biointerface Initiative Offers Promise Of Replacing Sensory Function.
Could advances in biointerface technology mean the blind see, the lame walk, and the deaf hear? A new initiative aims to find out.
New Patch Could Replace Routine Eye Injections
Researchers have developed a new system for delivering drugs to the back of the eye that could offer more effective treatment while sparing patients the excruciating routine of having drugs injected into their eyes by syringe every six to eight weeks.
Bioptigen’s Ophthalmic Imaging System Gains CE Mark
US ophthalmologic imaging technology company Bioptigen Inc., has received regulatory approval to market its hand-held Envisu C2000-series systems for clinical use within the European Union
Carl Zeiss Meditec Closes Financial Year on a High and Pursues Growth Course
Carl Zeiss Meditec bucks the trend with growth in all business areas and increased profitability.
OptiMedica Announces First Eu Cataract Cases Using Catalys™Precision Laser System
Californian company OptiMedica Corp. has announced that one member of its global Medical Advisory Board has become the first ophthalmic surgeon in Europe to treat patients with its Catalys Precision Laser System for cataract surgery.
CE Mark Approval for Bausch & Lomb Victus Femtosecond Laser
First Single-Platform Femtosecond Laser Now Commercially Available in European Union
Rayner Receives CE Mark Approval for Sulcoflex® Multifocal Toric IOL
Rayner Intraocular Lenses Limited, the world’s original manufacturer of IOLs, has received CE Mark approval for the Sulcoflex® Multifocal Toric IOL.
Optos Retinal Imaging Company Sales Up 35%, Operating Profit Up 43%
Optos plc (LSE: OPTS), a leading medical retinal imaging company, has announced strong preliminary results for the year ended 30 September 2011.
STAAR Surgical Receives CE Mark Approval For Its Toric Collamer® IOL
CE Mark for Staar Surgical Allows Company to Expand its Presence in the Premium IOL Market in Europe with the nanoFLEX(TM) Toric IOL. First Shipments are Scheduled for Q1 2012
Spooky Contacts Can Be a Nightmare for Your Eyes
Infections, even blindness, may result from nonprescription contact lenses, FDA warns